m+Medelevator.RU
← Поиск публикаций
Journal of Cancer · 2020

Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zarogoulidis Paul, Huang Haidong, Yang Meng, Zhou Jun, Jiao Yang, Wang Qin, Petridis Dimitris, Sapalidis Konstantinos, Sardeli Chrysanthi, Konsta Parthenopi, Koulouris Charilaos, Michalopoulos Nikolaos, Giannakidis Dimitrios, Barbetakis Nikolaos, Katsaounis Athanasios, Hohenforst-Schmidt Wolfgang, Amaniti Aikaterini, Petanidis Savvas, Tsakiridis Kosmas, Courcoutsakis Nikolaos, Goganau Alexandru Marian, Vagionas Anastasios, Romanidis Konstantinos, Oikonomou Panagoula, Karanikas Michael, Katsios Iason Nikolaos, Kesisoglou Isaak, Kosmidis Christoforos

Аннотация

Introduction: Immunotherapy is a treatment option for non-small cell lung cancer advanced disease. However; immunotherapy in several patients induces orogonitis and effusion in different cavities. It is up to the treating physician to understand whether there is effusion due to adverse effect or disease progression. Pleurodesis in both cases might be a solution for recurrent pleura effusion. Patients and Methods: Three hundred and thirty seven non-small cell lung cancer patients with adenocarcinoma and pleura effusion during first line immunotherapy treatment underwent medical thoracoscopy or Video assisted thoracic surgery (VATS) for pleurodesis with talk poudrage. Uniportal medical thoracoscopy was performed under general with dual channel endotracheal tube in one hundred and eleven patients. Video assisted thoracic surgery was performed in one hundred and eighty seven patients and conversion from medical to VATS procedure was done to thirty nine patients. All patients had stage IV disease with pleura involvement and were under first line pembrolizumab treatment with 200mg (PD-L1 ≥ 50%). Results: The quantitative parameters of the study (expression, PY and cycle) were converted to an ordinal scale to facilitate the performance of statistical analysis. All parameters were examined as dependent against the parameter technique acting as independent to detect potential relationships. The results of multi Y versus X relationship revealed no statistically significant effect (p>0.05) of the three levels of technique against any response considered. Thus we can infer, quite safely, that the innovative operation (level 0) does not differ from the other two conventional methods (levels 2 and 3) through all parameters entered in the model. There was no significant difference between the different pleurodesis techniques. Discussion: Immunotherapy is known to induce in a number of patients pleura effusion and pericarditis. However; pleurodesis is efficient when the appropriate method is performed to every patient. Careful assessment in a case by case manner has to be performed for each patient before any procedure is performed.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты